Grifols SA Files Routine 6-K Report
Ticker: GIKLY · Form: 6-K · Filed: Jul 30, 2024 · CIK: 1438569
| Field | Detail |
|---|---|
| Company | Grifols SA (GIKLY) |
| Form Type | 6-K |
| Filed Date | Jul 30, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, routine-report
TL;DR
Grifols filed a 6-K, just routine stuff, no news.
AI Summary
On July 30, 2024, Grifols, S.A. filed a Form 6-K to report relevant information. The filing is a standard report for foreign private issuers and does not contain specific financial transactions or material events beyond its routine disclosure nature.
Why It Matters
This filing indicates Grifols, S.A. is meeting its regular reporting obligations as a foreign private issuer with the SEC. It does not signal new developments but confirms ongoing compliance.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material information or significant financial events.
Key Players & Entities
- Grifols, S.A. (company) — Registrant
- 0001104659-24-083814 (filing_id) — Accession Number
- July 30, 2024 (date) — Filing Date
- 2834 (sic_code) — Pharmaceutical Preparations
FAQ
What type of filing is this for Grifols, S.A.?
This is a Form 6-K, which is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
What is the filing date of this report?
The filing date is July 30, 2024.
Where is Grifols, S.A. headquartered?
Grifols, S.A. is headquartered in Sant Cugat del Vallès, Barcelona, Spain.
What is the SIC code listed for Grifols, S.A.?
The Standard Industrial Classification (SIC) code listed is 2834, which corresponds to Pharmaceutical Preparations.
Does this filing indicate any specific new business developments or financial transactions?
No, the filing is described as 'Relevant Information' and appears to be a routine report for foreign private issuers, not detailing specific new transactions or events.
Filing Stats: 1,164 words · 5 min read · ~4 pages · Grade level 14 · Accepted 2024-07-30 11:12:47
Filing Documents
- tm2419599d2_6k.htm (6-K) — 21KB
- tm2419599d2_6kimg01.jpg (GRAPHIC) — 5KB
- 0001104659-24-083814.txt ( ) — 30KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. Grifols, S.A. By: /s/ David I. Bell Name: David I. Bell Title: Authorized Signatory Date: July 30, 2024